BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260916T170000
DTEND;TZID=Australia/Sydney:20260916T170000
DTSTAMP:20260602T045957Z
CREATED:20260602T045957Z
LAST-MODIFIED:20260602T045957Z
UID:10000300-1789578000-1789578000@melanoma.org.au
SUMMARY:MRFF International Clinical Trial Collaborations
DESCRIPTION:The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nPromote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.\nProvide high-quality evidence of the effectiveness of novel health treatments\, drugs or devices in ‘usual care’ settings\, which will support a decision on whether to deliver the intervention in an Australian setting.\n\nThe anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nPlease note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. \n\nKey Dates:\nMinimum data due: 19 August 2026\nApplications close: 16 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-int-clinical-trial-collaborations/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-International-Clinical-Trial-Collaborations-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261104T170000
DTEND;TZID=Australia/Sydney:20261104T170000
DTSTAMP:20260804T062313Z
CREATED:20260804T054341Z
LAST-MODIFIED:20260804T062313Z
UID:10000323-1793811600-1793811600@melanoma.org.au
SUMMARY:NHMRC Clinical Trials and Cohort Studies Grants
DESCRIPTION:Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge\, leading to relevant and implementable findings for the benefit of human health. \nThis funding scheme is open to research proposals for clinical trials and/or cohort studies of any size – that is\, they may be large or small clinical trials or cohort studies. \nThe intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and well-being\, health care practice or policy\, as a result of: \n\nHigh-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).\nHigh-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\nHigh quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.\n\n\nKey Dates:\nApplications open: 9 September 2026\nMinimum data due date: 7 October 2026\nApplications close: 4 November 2026 \nGuidelines will be available when the grant opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-clinical-trials-grants/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/07/NHMRC_Clinical_Trials_Grants-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR